[Ductal carcinoma in situ treated with radiation therapy and additional boost].

CONCLUSION: In our experience, women treated for a ductal carcinoma in situ with breast-conserving surgery and whole breast radiation therapy with a boost radiation have a high 10-year local recurrence-free survival rate. PMID: 25921619 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25921619?dopt=Abstract

Source: Cancer Radiotherapie - April 24, 2015 Category: Cancer & Oncology Authors: Geiss R, Cabel L, Touboul E, Lefranc JP, Daraï É, Lauratet B, Monnier L, Haberer-Guillerm S, Deluen F, Schlienger M, Huguet F Tags: Cancer Radiother Source Type: research